Skip to main content
BIFIDO. Co. Ltd logo

BIFIDO. Co. Ltd — Investor Relations & Filings

Ticker · 238200 ISIN · KR7238200000 KO Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2024-09-25 Major Shareholding Noti…
Country KR South Korea
Listing KO 238200

About BIFIDO. Co. Ltd

https://bifido.com/

BIFIDO Co., Ltd. is a biotechnology company established in 1999 that specializes in the human microbiome. The company's core focus is the research and development of human-derived Bifidobacterium strains for use in functional foods, supplements, and personal care products. BIFIDO operates an integrated platform that covers the entire process from the selection of probiotic and pharmabiotic candidates to the manufacturing of finished goods, marketed under brands like BIFIDOLAB. Its research, supported by extensive scientific papers and patents, targets areas such as immune regulation, cognitive health, and the development of microbiome-based therapeutics for various health conditions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in stake by Amicogen, Inc. in Bifido Co., Ltd.) and the purpose of the holding. This type of filing is categorized as a Major Shareholding Notification (MRQ) as it tracks significant changes in ownership thresholds.
2024-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is used to report changes in shareholdings by major shareholders or insiders. Based on the provided definitions, this falls under 'Major Shareholding Notification' (MRQ) as it details a significant change in share ownership (disposal of 2,454,000 shares by Amicogen, Inc. in BIFIDO Co., Ltd.).
2024-09-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company, often referred to as a '5% rule' filing. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2024-09-20 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a change in the company's largest shareholder (maximum shareholder). It details the transfer of shares, the identity of the new major shareholder (Hwanin Pharmaceutical), and the purpose of the acquisition (management participation). This type of disclosure is a standard regulatory announcement regarding corporate ownership structure, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to the target company's perspective or broader merger activity) or Share Issue/Capital Change.
2024-09-13 Korean
[기재정정]최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a change in the largest shareholder of the company 'Bifido'. It details the transfer of shares, the identity of the new largest shareholder (Whanin Pharm), and the purpose of the acquisition (management participation). This type of disclosure is a standard regulatory announcement regarding corporate ownership structure, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to full company takeovers/mergers) or Director's Dealing.
2024-09-13 Korean
기타경영사항(자율공시) (자기사채(제1,2회차 전환사채) 소각 결정의 건)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the company Bifido regarding the cancellation of convertible bonds (1st and 2nd series). It details the board's decision to retire debt instruments (bonds) that were previously acquired. This falls under capital structure changes and financing updates. Since it specifically relates to the cancellation/retirement of debt securities, it fits best under the Capital/Financing Update category.
2024-09-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.